ScoreWhy is Bafna Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.26%
- Poor long term growth as Operating profit has grown by an annual rate 9.76% of over the last 5 years
2
Flat results in Dec 25
- PAT(Q) At Rs 1.84 cr has Fallen at -30.4% (vs previous 4Q average)
- PBDIT(Q) Lowest at Rs 3.05 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at 7.97%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bafna Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bafna Pharma.
34.38%
0.67
51.13%
Sensex
8.53%
0.73
11.73%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.72%
EBIT Growth (5y)
9.76%
EBIT to Interest (avg)
4.30
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.24
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.34%
ROCE (avg)
8.44%
ROE (avg)
10.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
32
Price to Book Value
3.00
EV to EBIT
25.65
EV to EBITDA
17.99
EV to Capital Employed
2.55
EV to Sales
1.89
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
5.74%
ROE (Latest)
13.50%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
PAT(9M)
At Rs 8.35 cr has Grown at 160.12%
-7What is not working for the Company
PAT(Q)
At Rs 1.84 cr has Fallen at -30.4% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs 3.05 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 7.97%
PBT LESS OI(Q)
Lowest at Rs 0.62 cr.
NON-OPERATING INCOME(Q)
is 66.30 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is not working for Bafna Pharma.
Profit After Tax (PAT) - Quarterly
At Rs 1.84 cr has Fallen at -30.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.64 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 3.05 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 7.97%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.62 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 66.30 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
